Epilepsy Today Latest News

Epilim Chronosphere modified release granules

Epilim Chronosphere modified release 1,000mg granules are temporarily out of stock in the UK. This is due to an increase in demand. Sanofi expects to have them back in stock by mid-August 2019.

All other strengths of Epilim Chronosphere modified release granules are available. Other formulations of Epilim (sodium valproate) are also in stock.

Accord levetiracetam stock in the UK

Accord is out of stock of its version of levetiracetam 500mg tablets. Accord expects to have them back in stock by the end of August.

All other strengths of Accord levetiracetam tablets are in stock.

Exposure of babies to topiramate and valproate in womb linked to birth defects, study suggests

A new study in Neurology has shown an increased risk of birth defects in babies born to mothers taking medicines valproic acid and topiramate.

Frisium temporary shortage in the UK

Sanofi have told us that their supply of Frisium (clobazam) 10mg tablets has been significantly reduced over the past 2 weeks. This is due to a temporary manufacturing disruption, coupled with changes to packaging.

Sanofi say they are taking steps to speed up the delivery of Frisium to their suppliers, and expect to have stock back to normal levels by 5 July 2019.

Recall of some batches of Vimpat tablets in the UK

The Medicines and Healthcare products Regulatory Agency (MHRA) has announced a recall of some batches of 100mg Vimpat (lacosamide) tablets.

World Health Organization calls for action to reduce global issues around epilepsy

The World Health Organization (WHO) has released a 2019 report highlighting global concerns about epilepsy treatment.

Blood test may predict seizures, study suggests

Researchers may have found a way to predict seizures in people with epilepsy using a blood test, according to a new study in the Journal of Clinical Investigation.

Risk of behavioural problems higher in children exposed to four common epilepsy medicines in the womb, study suggests

A new study in Epilepsia has suggested that children exposed to four common epilepsy medicines in the womb may have an increased risk of behavioural problems.